FibroScan vs Ultrasound Elastography: CAP, kPa & Which Ultrasound Machine Is Best for Fatty Liver?

FibroScan vs Ultrasound Elastography: What Is the Difference?

Patients with Fatty Liver are increasingly offered non-invasive tests to assess liver fat and fibrosis. Two commonly discussed technologies are FibroScan (vibration-controlled transient elastography, VCTE) and ultrasound-based shear-wave elastography.

They are related, but a FibroScan result and an ultrasound elastography result should not be assumed to be numerically interchangeable. Different technologies, probes, acquisition methods and software can produce different measurements, so interpretation should use the method-specific evidence and clinical context.

What Does FibroScan Measure?

FibroScan is a dedicated non-invasive elastography system. It can provide:

• Liver stiffness measurement (LSM), reported in kPa, which is used to assess fibrosis risk.
• Controlled Attenuation Parameter (CAP), reported in dB/m, which estimates hepatic steatosis.

AASLD describes VCTE as a preferred secondary risk-assessment tool in many patients with MASLD because it can assess both fibrosis with liver stiffness and steatosis with CAP. AASLD non-invasive assessment guidance.

What Does a Modern Ultrasound Machine Measure?

A high-end ultrasound system can combine routine liver imaging with quantitative technologies such as:

• 2D shear-wave elastography (2D-SWE) or point shear-wave elastography to estimate liver stiffness.
• Ultrasound attenuation/fat quantification to estimate hepatic steatosis.
• Conventional B-mode imaging to assess liver morphology and associated abdominal findings.
• Color and spectral Doppler to evaluate vessels and portal/hepatic circulation when clinically indicated.

EASL recognizes transient elastography, point shear-wave elastography and 2D shear-wave elastography as non-invasive methods for measuring liver stiffness. Standard ultrasound, by itself, is useful for liver imaging and detecting steatosis but does not provide a direct fibrosis measurement. EASL Clinical Practice Guidelines on non-invasive tests.

CAP vs Ultrasound Fat Quantification

Feature	FibroScan	Advanced Ultrasound
Fat measurement	CAP, dB/m	Vendor-specific attenuation or fat-quantification metrics
Fibrosis assessment	VCTE liver stiffness, kPa	Shear-wave elastography, commonly kPa or m/s depending on system
Anatomical imaging	Limited compared with diagnostic US	Full liver and abdominal ultrasound
Doppler	Not the main purpose	Available
Gallbladder/biliary tract	Not a routine diagnostic strength	Can be assessed during the same examination
Lesion assessment	Limited	Major advantage of diagnostic ultrasound

Why kPa on FibroScan Is Not Automatically the Same as kPa on Ultrasound

Both technologies can report liver stiffness in kPa, but the number comes from different measurement systems. The physics, region sampled, transducer, acquisition technique, software and validated disease-specific thresholds can differ.

Therefore, if a FibroScan says 8.5 kPa and an ultrasound elastography examination says 8.5 kPa, you should not conclude that the two examinations have produced identical information. Use the reference ranges and clinical interpretation validated for that particular technique.

Which Is Better for Fatty Liver?

There is no single machine that is automatically superior for every clinical purpose. The best setup depends on whether your priority is dedicated fibrosis/steatosis risk stratification, comprehensive diagnostic ultrasound, or both.

FibroScan: Particularly useful when you want a dedicated, standardized VCTE-based assessment of liver stiffness and CAP, especially for serial fibrosis-risk assessment.

Advanced ultrasound with shear-wave elastography: Particularly useful when you want to perform a complete abdominal/liver examination and add quantitative stiffness and fat assessment in the same session.

EASL notes that transient elastography is the most widely validated and available elastography approach, while ultrasound-based point-SWE and 2D-SWE are also established liver-stiffness techniques. citeturn0search24

Which Ultrasound Features Matter Most in an Endocrine Clinic?

If the goal is to evaluate patients with Diabetes, insulin resistance, excess body weight and Fatty Liver, I would look for these capabilities when purchasing an ultrasound system:

1. Reliable 2D shear-wave elastography with a dedicated liver protocol.
2. Quantitative liver-fat assessment, not just visual grading of a bright liver.
3. Good penetration and image quality in patients with higher BMI.
4. Quality/confidence maps or reliability indicators for elastography.
5. Automated or assisted measurements that improve repeatability.
6. Excellent abdominal transducers and Doppler.
7. Easy storage/export of measurements for follow-up.

Samsung V8 vs Philips Affiniti for Fatty Liver Assessment

Both platforms can be configured with useful liver-elastography technologies.

Samsung V8

The Samsung V8 offers S-Shearwave Imaging for quantitative liver stiffness assessment. Samsung also lists TAI (Tissue Attenuation Imaging) and TSI (Tissue Scatter Distribution Imaging) for quantitative assessment of steatotic liver changes, along with HRI/EzHRI tools. These features make the V8 particularly interesting when liver fat and stiffness assessment are important parts of the practice. Samsung V8 brochure.

Philips Affiniti 50

The Affiniti 50 can be equipped with Auto ElastQ for automated liver elastography and real-time quantitative shear-wave measurements. Philips also offers liver fat quantification technologies and advanced transducers for technically difficult patients. Philips Affiniti 50.

Philips Affiniti 70

The Affiniti 70 sits higher in the Affiniti range and supports Philips’ advanced liver assessment ecosystem, including ElastQ 2D shear-wave elastography and Auto ElastQ when appropriately configured. Philips highlights confidence maps, quantitative stiffness assessment and workflow assistance for liver evaluation. Philips shear-wave elastography.

For a High-Volume Endocrine Clinic: What Would I Look For?

If your main requirement is Diabetes + Fatty Liver + Weight Loss + routine abdominal/thyroid ultrasound, I would prioritize an ultrasound platform with both strong general imaging and advanced liver quantification rather than buying a system only for elastography.

My practical shortlist:

• Philips Affiniti 70 with ElastQ/Auto ElastQ and appropriate liver-fat quantification: a strong premium option when budget permits and you want a comprehensive ultrasound platform.
• Samsung V8 with S-Shearwave + TAI/TSI: a very attractive option when quantitative Fatty Liver assessment is a major priority and you want a broad general-imaging platform.
• Philips Affiniti 50 with the appropriate elastography/fat-quantification package: a practical middle-ground option with strong liver imaging and elastography capability.

The exact software package, transducer, licensing and local configuration should be confirmed in the quotation. Do not purchase an ultrasound simply because the brochure says “elastography”; confirm the actual liver 2D-SWE/point-SWE, fat-quantification and quality-control features included in your specific machine.

Can Ultrasound Elastography Replace FibroScan?

Not automatically. Both are useful non-invasive liver-stiffness techniques, but they are not identical tests. If you are following a patient over time, consistency of technique is important. A patient measured repeatedly by one validated method should generally be followed using the same method where practical, rather than comparing raw numbers from different machines without context.

What Should a Fatty Liver Assessment Include?

A good metabolic-liver assessment may combine:

• Clinical history and examination
• Liver enzymes and metabolic blood tests
• FIB-4 or another validated blood-based fibrosis score
• Ultrasound for liver and abdominal anatomy
• CAP/VCTE or ultrasound shear-wave elastography when indicated
• Further hepatology assessment or MR elastography in selected patients

No single number should be interpreted in isolation. EASL emphasizes that liver stiffness can be affected by inflammation, cholestasis, food intake, exercise and venous congestion, and recommends appropriate technique and clinical context when interpreting non-invasive tests. citeturn0search24

Key Takeaways

• CAP is a FibroScan-specific attenuation parameter for estimating liver fat.
• kPa can be reported by both FibroScan and ultrasound elastography, but the measurements are method-specific.
• Standard ultrasound alone does not measure fibrosis.
• Advanced ultrasound can combine anatomy, Doppler, liver fat quantification and shear-wave elastography in one examination.
• For a comprehensive endocrine clinic, a high-quality ultrasound with liver elastography and quantitative fat assessment can complement—not necessarily replace—FibroScan.
• For your clinic, the Philips Affiniti 70 and Samsung V8 are both technically strong candidates; the final choice should depend on the exact liver software package, transducers, service support, workflow and quotation.

References

1. AASLD: Noninvasive Assessment of Patients With MASLD
2. EASL: Clinical Practice Guidelines on Non-invasive Tests
3. Samsung V8 official brochure
4. Philips Shear Wave Elastography
5. Philips Affiniti 50

Consult Dr. Moxit Shah, DM Endocrinology in Ahmedabad

For evaluation of Diabetes, Fatty Liver, Weight Loss and metabolic disorders:

Vishuddha Endocrine Clinic
104-105, Elite Magnum, Bhuyangdev Cross Road, Opp. Utsav Elegance, Vardhmannagar Society, Ghatlodiya/Memnagar, Ahmedabad, Gujarat 380061
Phone: +91 99799 92797

Dr. Moxit Shah, DM Endocrinology